40 related articles for article (PubMed ID: 27829520)
1. Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1.
Kolossov VL; Ponnuraj N; Beaudoin JN; Leslie MT; Kenis PJ; Gaskins HR
Biochem Biophys Res Commun; 2017 Jan; 483(1):680-686. PubMed ID: 27986568
[TBL] [Abstract][Full Text] [Related]
2. A near-infrared fluorescent probe with two-photon excitation for in situ imaging of NQO1 in human colorectum cancer tissue.
Jiang W; An W; Huang Z; Xu C; Shen Q; Pu C; Zhang S; Wu Q; Li L; Yu C
Talanta; 2024 Jul; 274():126018. PubMed ID: 38593645
[TBL] [Abstract][Full Text] [Related]
3. Structural dynamics at the active site of the cancer-associated flavoenzyme NQO1 probed by chemical modification with PMSF.
Grieco A; Ruiz-Fresneda MA; Gómez-Mulas A; Pacheco-García JL; Quereda-Moraleda I; Pey AL; Martin-Garcia JM
FEBS Lett; 2023 Nov; 597(21):2687-2698. PubMed ID: 37726177
[TBL] [Abstract][Full Text] [Related]
4. NQO1-activated multifunctional theranostic probe for imaging-guided mitochondria-targeted photodynamic therapy and boosting immunogenic cell death.
Cao C; Li J; Zhang X; Zhang X; Gong X; Wang S
Talanta; 2024 May; 272():125786. PubMed ID: 38382303
[TBL] [Abstract][Full Text] [Related]
5.
Behera SK; Lambring CB; Hashmi A; Gottipolu S; Basha R
Eur J Biol; 2023 Dec; 82(2):280-288. PubMed ID: 38264080
[TBL] [Abstract][Full Text] [Related]
6. Deploying Fluorescent Nucleoside Analogues for High-Throughput Inhibitor Screening.
Seebald L; Madec AGE; Imperiali B
Chembiochem; 2020 Jan; 21(1-2):108-112. PubMed ID: 31709708
[TBL] [Abstract][Full Text] [Related]
7. Covalent-Assembly Based Fluorescent Probes for Detection of hNQO1 and Imaging in Living Cells.
Han J; Cheng L; Zhu Y; Xu X; Ge C
Front Chem; 2020; 8():756. PubMed ID: 33005608
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of a carboxylesterase detection probe with therapeutic effects.
Lin X; Liu M; Yi Q; Zhou Y; Su J; Qing B; Lu Y; Pu C; Lan W; Zou L; Wang J
Talanta; 2024 Jul; 274():126060. PubMed ID: 38604044
[TBL] [Abstract][Full Text] [Related]
9. An in silico approach to investigate the theranostic potential of coumarin-derived self-immolative luminescent probes.
Venkatesan S; Chanda K; Balamurali MM
Chem Biodivers; 2024 Feb; 21(2):e202301400. PubMed ID: 38109279
[TBL] [Abstract][Full Text] [Related]
10. Affinity probes based on small-molecule inhibitors for tumor imaging.
Yi X; Wang Z; Hu X; Yu A
Front Oncol; 2022; 12():1028493. PubMed ID: 36387103
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo.
Punganuru SR; Madala HR; Arutla V; Srivenugopal KS
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30487423
[TBL] [Abstract][Full Text] [Related]
13. Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.
Bian J; Li X; Xu L; Wang N; Qian X; You Q; Zhang X
Eur J Med Chem; 2017 Feb; 127():828-839. PubMed ID: 27829520
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
[TBL] [Abstract][Full Text] [Related]
15. Alkynyloxy derivatives of 5,8-quinolinedione: Synthesis, in vitro cytotoxicity studies and computational molecular modeling with NAD(P)H:Quinone oxidoreductase 1.
Kadela-Tomanek M; Jastrzębska M; Pawełczak B; Bębenek E; Chrobak E; Latocha M; Książek M; Kusz J; Boryczka S
Eur J Med Chem; 2017 Jan; 126():969-982. PubMed ID: 28006669
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y
Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.
Zhang K; Chen D; Ma K; Wu X; Hao H; Jiang S
J Med Chem; 2018 Aug; 61(16):6983-7003. PubMed ID: 29712428
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.
Pey AL; Megarity CF; Timson DJ
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
